InsiderClue
Insiders · Profile

Third Rock Ventures III, L.P.

10% owner at Voyager Therapeutics · 10% owner at Revolution Medicines · 10% owner at Relay Therapeutics · and 1 more. Filing since 22 Jul 2019. CIK 0001569705

VYGR Voyager Therapeutics, Inc. 10% owner · 13 trades RVMD Revolution Medicines, Inc. 10% owner · 1 trade RLAY Relay Therapeutics, Inc. 10% owner · 4 trades FULC Fulcrum Therapeutics, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
VYGR Voyager Therapeutics, Inc.
1 Feb 2023
10% owner
Sold, plan not stated
128,642
$1.20M
2.7%
VYGR Voyager Therapeutics, Inc.
31 Jan 2023
10% owner
Sold, plan not stated
185,000
$1.71M
3.7%
VYGR Voyager Therapeutics, Inc.
30 Jan 2023
10% owner
Sold, plan not stated
75,000
$677.25K
1.5%
VYGR Voyager Therapeutics, Inc.
27 Jan 2023
10% owner
Sold, plan not stated
50,000
$451.00K
1.0%
VYGR Voyager Therapeutics, Inc.
25 Jan 2023
10% owner
Sold, plan not stated
50,000
$461.00K
1.0%
VYGR Voyager Therapeutics, Inc.
24 Jan 2023
10% owner
Sold, plan not stated
100,000
$927.00K
1.9%
VYGR Voyager Therapeutics, Inc.
23 Jan 2023
10% owner
Sold, plan not stated
55,000
$498.30K
1.0%
VYGR Voyager Therapeutics, Inc.
20 Jan 2023
10% owner
Sold, plan not stated
100,000
$915.00K
1.8%
VYGR Voyager Therapeutics, Inc.
25 Aug 2022
10% owner
Sold, plan not stated
200,000
$1.24M
3.6%
VYGR Voyager Therapeutics, Inc.
24 Aug 2022
10% owner
Sold, plan not stated
149,972
$913.33K
2.6%
VYGR Voyager Therapeutics, Inc.
16 Aug 2022
10% owner
Sold, plan not stated
128,456
$775.87K
2.2%
VYGR Voyager Therapeutics, Inc.
15 Aug 2022
10% owner
Sold, plan not stated
135,808
$820.28K
2.2%
VYGR Voyager Therapeutics, Inc.
12 Aug 2022
10% owner
Sold, plan not stated
348,007
$2.13M
5.4%
RVMD Revolution Medicines, Inc.
8 Jun 2022
10% owner
Sold, plan not stated
419,901
$8.50M
7.6%
RLAY Relay Therapeutics, Inc.
14 Jan 2021
10% owner
Sold, plan not stated
1,965,294
$80.58M
100%
RLAY Relay Therapeutics, Inc.
13 Jan 2021
10% owner
Sold, plan not stated
1,311,197
$52.61M
14.5%
RLAY Relay Therapeutics, Inc.
13 Jan 2021
10% owner
Sold, plan not stated
845,903
$33.94M
30.1%
RLAY Relay Therapeutics, Inc.
12 Jan 2021
10% owner
Sold, plan not stated
1,500,000
$60.00M
14.2%
FULC Fulcrum Therapeutics, Inc.
22 Jul 2019
10% owner
Bought
81,250
$1.30M
1.4%
19 decisions on file.